Review
doi: 10.1097/NAN.0000000000000248.
The Role of Immunoglobulin in the Treatment of Immune-Mediated Peripheral Neuropathies
Affiliations
- PMID: 29112586
- DOI: 10.1097/NAN.0000000000000248
Item in Clipboard
Review
The Role of Immunoglobulin in the Treatment of Immune-Mediated Peripheral Neuropathies
J Infus Nurs.
2017 Nov/Dec.
Abstract
Immune-mediated neuropathies are a group of peripheral nerve disorders characterized by motor or sensory deficits caused by inflammation leading to demyelination or axonal injury. Intravenous immunoglobulin (IVIg) has been demonstrated to be an effective therapy for the 3 most common immune-mediated neuropathies: Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. This review summarizes current data on the rationale for the use of IVIg in immune-mediated neuropathies, addressing mechanism of action, clinical evidence, and practical considerations for its use.
Similar articles
-
Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies.Neurology. 2002 Dec 24;59(12 Suppl 6):S13-21. doi: 10.1212/wnl.59.12_suppl_6.s13. Neurology. 2002. PMID: 12499466 Review.
-
Therapy of immune neuropathies with intravenous immunoglobulins.J Neurol. 2006 Sep;253 Suppl 5:V59-63. doi: 10.1007/s00415-006-5008-9. J Neurol. 2006. PMID: 16998755 Review.
-
High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.Neurol Sci. 2002 Apr;23 Suppl 1:S25-32. doi: 10.1007/s100720200012. Neurol Sci. 2002. PMID: 12032584 Review. No abstract available.
-
Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review.Curr Drug Saf. 2019;14(1):3-13. doi: 10.2174/1574886313666181017121139. Curr Drug Saf. 2019. PMID: 30332974 Review.
-
Immunotherapy of idiopathic inflammatory neuropathies.Muscle Nerve. 2003 Sep;28(3):273-92. doi: 10.1002/mus.10402. Muscle Nerve. 2003. PMID: 12929187 Review.
Cited by
-
Implications of anti-ganglioside antibodies in isolated dysphagia following COVID-19 infection: Case series.Brain Behav. 2024 May;14(5):e3514. doi: 10.1002/brb3.3514. Brain Behav. 2024. PMID: 38698593 Free PMC article.
-
Expanding the Role of the Pharmacist: Immunoglobulin Therapy and Disease Management in Neuromuscular Disorders.J Pharm Pract. 2022 Feb;35(1):106-119. doi: 10.1177/0897190020938212. Epub 2020 Jul 17. J Pharm Pract. 2022. PMID: 32677504 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
